This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Menu
Close
Example content
Adverse event reporting can be found at the bottom of the page
Prescribing information can be found at the bottom of the page.
Join us on 25 April 2025 to hear from Dr Krishna Dani, Consultant Neurologist discussing Challenging Cases in Migraine Management followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer.
Prescribing information can be found at the bottom of the page.
Join us on 25 April 2025 to hear from Dr Krishna Dani, Consultant Neurologist discussing Challenging Cases in Migraine Management followed by a live interactive Q&A.
This promotional meeting is organised and funded by Pfizer Ltd for UK HCPs and will include reference to medicines promoted by Pfizer.
Dr Krishna Dani is a Consultant Neurologist based in Glasgow.
Dr Dani's undergraduate education comprised of an intercalated degree in Neuroscience from Imperial College London and his medical degree was awarded from the University of Glasgow in 2003.
Dr Dani completed neurology training in Glasgow in 2016 and trained in research techniques at the National Institute of Health (Bethesda USA). He was awarded his PhD in metabolic brain imaging from the University of Glasgow.
Dr Dani is currently based at the Institute of Neurological Sciences Glasgow. He works in general neurology and is the lead for the headache service in Glasgow.
Dr Dani is an Honorary Council Advisor to the British Association for the Study of Headache (BASH). He was one of the main authors of the SIGN 155 Pharmacological Management of Migraine updates in March 2023. He was also an author of the NHS Scotland National Headache Pathway published in October 2023.
Vydura®▼(rimegepant)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Pfizer Medical Information on 01304 616161.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2025 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-UNP-GBR-7812. January 2024.